Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit)

July 29, 2020 updated by: Fred Hutchinson Cancer Center

Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation

The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

2637

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98109
        • Fred Hutchinson Cancer Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 18 or older
  • smokes at least five cigarettes daily for at least past 12 months
  • wants to quit in next 30 days
  • willing to be randomly assigned to either group
  • resides in US
  • has at least weekly access to a high speed Internet connection and email
  • willing and able to read in English
  • not participating in other smoking cessation interventions (including our other intervention studies
  • has never used the Smokefree.gov website
  • willing to complete all three follow-up surveys
  • provide email, phone, and mailing address
  • provide contact information for two collaterals (e.g., relatives).
  • does not have family, friends, or other household members participating

Exclusion Criteria:

  • The exclusion criteria are the opposite of the inclusion criteria above.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: CBT
Cognitive Behavioral Therapy
Other Names:
  • Cognitive Behavioral Therapy
Experimental: ACT
Acceptance & Commitment Therapy
Other Names:
  • Acceptance & Commitment Therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30-day point prevalence abstinence
Time Frame: 12 month post randomization
No smoking in the past 30 days, as reported 12 month post treatment.
12 month post randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
7-day, 24-hour, and 30-day point prevalence quit rates
Time Frame: 3 months, 6 months, and 12 months post treatment
12 months: 24-hour and 7-day point prevalence quit rates. 3 and 6 months: 24-hour, 7-day, and 30-day point prevalence quit rates. Across 3, 6, and 12 month timepoints, the repeated 30-day point prevalence abstinence.
3 months, 6 months, and 12 months post treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 24, 2014

Primary Completion (Actual)

October 26, 2016

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

March 14, 2013

First Submitted That Met QC Criteria

March 14, 2013

First Posted (Estimate)

March 18, 2013

Study Record Updates

Last Update Posted (Actual)

July 31, 2020

Last Update Submitted That Met QC Criteria

July 29, 2020

Last Verified

December 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 7859
  • NCI-2019-06975 (Registry Identifier: NCI / CTRP)
  • R01CA166646 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe